ALLIEVA PHARMA PRIVATE LIMITED, a leading oncology medicine supplier and pharmaceutical exporter from India, proudly participated in Arab Health 2026 in Dubai.
Written by Chandan Kumar | Published on Feb. 16, 2026
At Arab Health 2026, our team introduced a wide range of high-quality oncology medicines including:
• Chemotherapy injections
• Targeted therapy medicines
• Hormonal cancer treatments
• Oncology injectable formulations
• Critical care pharmaceutical products
Our portfolio includes widely demanded oncology molecules such as Methotrexate Injection, Doxorubicin Injection, Azacitidine Injection, Carboplatin Injection, Cisplatin Injection, Oxaliplatin Injection, and various other anti-cancer medicines.
As a trusted pharmaceutical distributor and exporter, we focus on delivering WHO-GMP quality medicines with reliable global supply chains.
Participation in Arab Health strengthened our position as a growing oncology pharmaceutical exporter from India. We connected with:
• International pharmaceutical distributors
• Oncology medicine importers
• Hospital procurement teams
• Healthcare supply chain companies
The event created new opportunities in Middle East, Africa, and other international markets looking for affordable and high-quality cancer treatment medicines.
At ALLIEVA PHARMA PRIVATE LIMITED, our mission is to improve global access to life-saving oncology medicines. We are committed to:
• Supplying affordable anti-cancer medicines
• Ensuring consistent product quality
• Maintaining regulatory compliance
• Supporting global healthcare partners
Our participation at Arab Health 2026 reflects our dedication to expanding access to advanced oncology treatments worldwide.
If you are looking for a reliable oncology injection supplier or pharmaceutical export partner from India, connect with ALLIEVA PHARMA PRIVATE LIMITED to explore business opportunities.
Contact us today to discuss distribution and bulk supply inquiries.
Explore more pharma blogs and news from Allieva Pharma.
